Integrated Biopharma, Inc. INBP
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.37M | -837.00K | -762.00K | 123.00K | -178.00K |
| Total Depreciation and Amortization | 374.00K | 356.00K | 331.00K | 327.00K | 327.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 593.00K | -154.00K | -73.00K | 120.00K | 854.00K |
| Change in Net Operating Assets | -795.00K | 1.15M | 1.12M | 731.00K | -412.00K |
| Cash from Operations | -1.19M | 517.00K | 617.00K | 1.30M | 591.00K |
| Capital Expenditure | -149.00K | 0.00 | -24.00K | -173.00K | 10.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 6.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -14.00K |
| Cash from Investing | -149.00K | 6.00K | -24.00K | -173.00K | -4.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -12.00K | -11.00K | -11.00K | -11.00K | -1.00K |
| Issuance of Common Stock | -- | -- | -- | -- | 68.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -12.00K | -11.00K | -11.00K | -11.00K | 67.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.36M | 512.00K | 582.00K | 1.12M | 654.00K |